Lybalvi: The Diet Olanzapine
The Carlat Psychiatry Report, Volume 20, Number 2, February 2022
https://www.thecarlatreport.com/newsletter-issue/tcprv20n2/
Issue Links: Learning Objectives | Editorial Information
Topics: Antipsychotics | Metabolic syndrome | Metformin | News of Note | Novel drug | Obesity | olanzapine | Side Effects | Waist circumference | Weight gain | Weight Loss Medications
Chris Aiken, MD.
Editor-in-Chief, The Carlat Psychiatry Report
Lybalvi hopes to lower the risk of weight gain on olanzapine by combining it with an opioid blocker (samidorphan). But how does it compare to generic options like metformin and naltrexone?
You can't view details of this content, please login or buy subscription here